Eli Lilly announced a partnership with Walmart on Wednesday to expand access to its GLP-1 Zepbound through LillyDirect, marking LillyDirect’s first retail collaboration.

LillyDirect is Eli Lilly’s direct-to-consumer digital healthcare platform and online pharmacy service. It offers access to medications for patients living with obesity, migraines and diabetes. Patients have the choice to use their insurance or self-pay for certain medications.

Typically, patients accessing Zepbound through LillyDirect receive free home delivery, but the partnership with Walmart gives them the option to pick it up at their local Walmart pharmacy as well. Those with a prescription for Zepbound can access the medication for $349 per month for a 2.5 mg dose, and $499 a month for all other doses.

Patients

See Full Page